Mabura 40 Pen – Uses, Dosage, Composition, Side Effects | Hetero Healthcare

Mabura 40 Pen is a prescription biologic medicine used in the treatment of chronic inflammatory and autoimmune conditions such as psoriasis, ankylosing spondylitis, rheumatoid arthritis, ulcerative colitis, and Crohn’s disease. It contains adalimumab, a monoclonal antibody that targets and blocks tumor necrosis factor-alpha (TNF-α), a substance in the body responsible for inflammation. By reducing excessive immune response, Mabura 40 Pen helps relieve pain, swelling, stiffness, and other symptoms associated with these disorders.

Mabura 40 pen composition includes adalimumab as the active ingredient, delivered through a pre-filled pen for convenient subcutaneous injection. This targeted therapy works by binding specifically to TNF-α and preventing it from interacting with its receptors, thereby reducing inflammation and preventing further joint or tissue damage.

Mabura 40 pen uses extend across multiple inflammatory conditions. In rheumatoid arthritis and ankylosing spondylitis, it helps improve mobility and reduce joint destruction. For psoriasis, it decreases skin inflammation and plaque formation. In ulcerative colitis and Crohn’s disease, it reduces intestinal inflammation and promotes symptom control, improving overall quality of life.